These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 11565255)

  • 1. [Translational control and pathogenesis of hepatitis C virus].
    Tsukiyama-Kohara K
    Uirusu; 2001 Jun; 51(1):1-9. PubMed ID: 11565255
    [No Abstract]   [Full Text] [Related]  

  • 2. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
    Jarczak D; Korf M; Beger C; Manns MP; Krüger M
    FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral hepatitis and liver cancer: the case of hepatitis C.
    Levrero M
    Oncogene; 2006 Jun; 25(27):3834-47. PubMed ID: 16799625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Host factors involved in regulation of replication and pathogenesis of hepatitis C virus ].
    Moriisi K; Mori Y; Taguwa S; Matsuura Y
    Tanpakushitsu Kakusan Koso; 2009 Jun; 54(8 Suppl):940-6. PubMed ID: 21089521
    [No Abstract]   [Full Text] [Related]  

  • 5. 3-Amino-2(5H)furanones as inhibitors of subgenomic hepatitis C virus RNA replication.
    Iannazzo D; Piperno A; Romeo G; Romeo R; Chiacchio U; Rescifina A; Balestrieri E; Macchi B; Mastino A; Cortese R
    Bioorg Med Chem; 2008 Nov; 16(21):9610-5. PubMed ID: 18835180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unravelling hepatitis C virus replication from genome to function.
    Lindenbach BD; Rice CM
    Nature; 2005 Aug; 436(7053):933-8. PubMed ID: 16107832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control.
    Chang PC; Chi CW; Chau GY; Li FY; Tsai YH; Wu JC; Wu Lee YH
    Oncogene; 2006 Mar; 25(14):1991-2003. PubMed ID: 16301996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential applications of siRNA in hepatitis C virus therapy.
    Smolic R; Volarevic M; Wu CH; Wu GY
    Curr Opin Investig Drugs; 2006 Feb; 7(2):142-6. PubMed ID: 16499284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of hepatitis C virus replication by microRNAs.
    Pietschmann T
    J Hepatol; 2009 Mar; 50(3):441-4. PubMed ID: 19155089
    [No Abstract]   [Full Text] [Related]  

  • 10. A human liver cell line exhibits efficient translation of HCV RNAs produced by a recombinant adenovirus expressing T7 RNA polymerase.
    Aoki Y; Aizaki H; Shimoike T; Tani H; Ishii K; Saito I; Matsuura Y; Miyamura T
    Virology; 1998 Oct; 250(1):140-50. PubMed ID: 9770428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel sequence found at the 3' terminus of hepatitis C virus genome.
    Tanaka T; Kato N; Cho MJ; Shimotohno K
    Biochem Biophys Res Commun; 1995 Oct; 215(2):744-9. PubMed ID: 7488017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem-loop structures II-IV of the 5' untranslated sequences are required for the expression of the full-length hepatitis C virus genome.
    Qi ZT; Kalkeri G; Hanible J; Prabhu R; Bastian F; Garry RF; Dash S
    Arch Virol; 2003 Mar; 148(3):449-67. PubMed ID: 12607098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCV and interferon: viral strategies for evading innate defence mechanisms in the virus-host battle.
    Capobianchi MR; Abbate I; Cappiello G; Solmone M
    Cell Death Differ; 2003 Jan; 10 Suppl 1():S22-4. PubMed ID: 12655342
    [No Abstract]   [Full Text] [Related]  

  • 15. Transcriptomic comparison of human hepatoma Huh-7 cell clones with different hepatitis C virus replication efficiencies.
    Inoue Y; Murakami K; Hmwe SS; Aizaki H; Suzuki T
    Jpn J Infect Dis; 2007 Jul; 60(4):173-8. PubMed ID: 17642525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatitis virus--the approach to clarification of the mechanisms of virus proliferation and the development of its control means].
    Kato N
    Uirusu; 2002 Jun; 52(1):157-62. PubMed ID: 12227167
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel insights into hepatitis C virus replication and persistence.
    Bartenschlager R; Frese M; Pietschmann T
    Adv Virus Res; 2004; 63():71-180. PubMed ID: 15530561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive and negative effects on translation of the hepatitis C virus 3' untranslated region.
    Wiklund L; Spångberg K; Schwartz S
    J Hum Virol; 2002; 5(1):8-16. PubMed ID: 12352263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibition of hepatitis C virus gene expression by antisense nucleotide in vitro].
    Li YN; Yu M; Wu WQ; Gao JX; Wang H; Ji SP; Wang QH; Si CW
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):341-3. PubMed ID: 15650784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ultrastructural reactions of liver cell populations during exposure to RNA- and DNA-genomic hepatitis C+B virus].
    Nepomniashchikh GI; Tolokonskaia NP; Aĭdagulova SV; Nepomniashchikh DL; Sakharova EG; Mezentseva GA; Savchenko IaE
    Biull Eksp Biol Med; 1999 Jul; 128(7):101-5. PubMed ID: 10485065
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.